 |
Transgene close to global lung cancer dealTransgene is close to a worldwide partnership deal for lung cancer vaccine TG4010, bringing the French research-based biotechnology company nearer its goal of becoming a biopharmaceutical group by 2016. Chief executive Philippe Archinard t More… |
Thursday 18 April 2024
